Mazor Robotics (NSDQ:MZOR) said it’s planning the début of a new brain module for its Renaissance robotic surgery system next week.
Neuromodulation/Neurostimulation
Axonics raises $33M for its neuromodulation tech
Axonics Modulation Technologies said it drummed up a $32.6 million Series A round for the neuromodulation technology it’s developing to treat chronic pain and overactive bladder.
Irvine, Calif.-based Axonics said the round was led by Edmond de Rothschild Investment Partners and included NeoMed Management, Legend Capital and "a select group of private individuals."
St. Jude’s Prodigy chronic pain neurostim device lands CE Mark
St. Jude Medical (NYSE:STJ) said it’s putting its Prodigy neurostimulation device on the market in Europe for patients with chronic back pain after winning CE Mark approval.
Oculeve raises $16.6M in support of dry eye disease treatment
San Francisco startup Oculeve Inc. closed a $16.6 million funding round in supports of its implantable technology for treatment of dry eye disease.
Mainstay Medical launches human trial of pain-relief stimulation implant
Dublin-based Mainstay Medical touted the launch of a new clinical trial evaluating its ReActiv8 implantable neurostimulator at 3 clinical sites in Australia.
FDA approves breakthrough migraine prevention device
FDA regulators today announced landmark approval of a mobile headband-like device indicated for prevention of migraines and migraine pain. The device, called the Cefaly system, is the 1st of its kind and is indicated as an alternative to drug therapy.
Brainsway raises $11.8M for neurological stimulation
Israeli stimulation devices maker Brainsway (PINK:BRSYF) raised about $11.8 million (NIS 41 million) thanks to a private placement investment from Yelin Lapidot Investment House.
Weight-loss: FDA bumps EnteroMedics’ advisory meeting for VBLOC neurostimulation system
Minnesota medical device maker EnteroMedics (NSDQ:ETRM) announced today that its May 2014 date the FDA had been bumped a few months back.
UPDATED: Medtronic denies involvement with on-demand orgasm implant
Report: Medtronic signs on to test on-demand orgasm device
Report: FDA panel recommends Inspire Medical’s sleep apnea implant
Updated February 24, 2014, with details from Inspire Medical.
An expert panel of FDA advisors voted today to recommend approval for Inspire Medical’s sleep apnea implant, the Inspire II Upper Airway Stimulator, the company confirmed.